Corrigendum to "Protection of Stroke-induced Blood-Brain Barrier Disruption by Guanxinning Injection and Its Active-component Combination via TLR4/NF-κB/MMP9-mediated Neuroinflammation" [Phytomedicine. 2025 Nov; 147:157162].

IF 11.3 1区医学 Q1 CHEMISTRY, MEDICINAL

Phytomedicine Pub Date : 2026-09-01 Epub Date: 2026-06-27 DOI:10.1016/j.phymed.2026.158438

Siwen Fan, Hongying Du, Yixin Yao, Huanyi Wang, Min Zhang, Xuliu Shi, Jiankun Yan, Li Peng, Guangxu Xiao, Shuang He, Ming Lyu, Yan Zhu

引用次数: 0

查看原文本刊更多论文

“冠心宁注射液及其有效成分联合应用TLR4/NF-κB/ mmp9介导的神经炎症对脑卒中血脑屏障破坏的保护作用”[植物医学]。2025年11月;147:157162]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Phytomedicine 医学-药学

CiteScore

10.30

自引率

5.10%

发文量

670

审稿时长

91 days

期刊介绍： Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.